Pharmacy Technician Certification Exams — Pharmacy Technician Certification Exam PTCE Blueprint
Answer: B
Trailing zeros may lead to errors in transcribing prescriptions.
Errors in transcribing prescriptions can occur due to the use of trailing zeros, which can create confusion in numerical values. For instance, writing "1.0 mg" may be misread as "10 mg," leading to significant dosing errors.
A) E-prescribing
E-prescribing is generally considered to enhance the accuracy of prescription writing by reducing handwriting errors and improving clarity. While it can still have its own issues, such as software glitches or miscommunication, it is not typically associated with transcription errors in the same way that trailing zeros are.
B) Trailing zeros
Trailing zeros can indeed lead to serious errors in prescription transcriptions. When a decimal number includes a trailing zero, it may be misinterpreted, causing potential overdosing or underdosing due to misreading the intended dosage. This issue is explicitly highlighted by the ISMP as a common source of medication errors.
C) Leading zeros
Leading zeros, on the other hand, are encouraged to prevent misinterpretation of dosages. For example, writing "0.5 mg" instead of ".5 mg" helps ensure that the dose is clearly understood. Therefore, leading zeros are not a source of transcription errors and may actually help prevent them.
D) Tall Man lettering
Tall Man lettering is a strategy used to distinguish between look-alike drug names and is not related to transcription errors. It serves to improve clarity and reduce the risk of medication errors by emphasizing differences in drug names, rather than contributing to confusion in dosage transcription.
Conclusion
Trailing zeros are a critical factor in prescription transcription errors, leading to potential misinterpretation of dosages. In contrast, e-prescribing, leading zeros, and Tall Man lettering are strategies that aim to enhance safety and clarity in medication management. Thus, trailing zeros represent a significant risk in the transcription process, making Option B the definitive correct answer.
Answer: C
Cleaning a tray used to count out anastrozole tablets is necessary due to handling precautions related to hazardous drugs.
Anastrozole is classified as a hazardous drug, which means that it requires specific handling and safety protocols to minimize exposure and prevent contamination. Therefore, cleaning the tray after use is essential to ensure safety.
A) aseptic technique
Aseptic technique refers to procedures designed to prevent contamination by pathogens, focusing on maintaining sterility rather than specifically addressing hazardous drugs. While aseptic technique is important in many pharmaceutical practices, it does not directly relate to the need for cleaning due to the hazardous nature of anastrozole.
B) antiretroviral agents
Antiretroviral agents are medications used to treat HIV/AIDS and are not related to anastrozole, which is used in the treatment of breast cancer. The cleaning of the tray is not specifically linked to antiretroviral agents, making this option incorrect.
C) hazardous drugs
Anastrozole is classified as a hazardous drug, which requires careful handling to prevent exposure to harmful effects. The necessity to clean the tray after counting these tablets is directly related to the precautions associated with hazardous drugs, making this option correct.
D) allergic reactions
While allergic reactions to medications are a concern in pharmaceutical practices, they do not specifically necessitate the cleaning of a tray used for counting anastrozole tablets. Allergic reactions are more about patient safety rather than the contamination of surfaces, thus making this option incorrect.
Conclusion
The requirement to clean the tray after handling anastrozole tablets is primarily due to its classification as a hazardous drug, which necessitates strict handling protocols. Options A, B, and D do not address the specific safety concerns related to hazardous drugs, confirming that C is the only correct answer in this context.
3. A spacer may be used with a:
Answer: D
A spacer may be used with a metered-dose inhaler.
A spacer is an accessory device that can be used with a metered-dose inhaler (MDI) to improve the delivery of medication to the lungs. It helps by allowing larger medication particles to settle out, making it easier for patients to inhale the medication effectively.
A) nasal spray.
A nasal spray is designed for direct application in the nasal passages and does not require a spacer. The mechanism of delivery is fundamentally different from that of a metered-dose inhaler, as nasal sprays operate independently without the need for additional devices to enhance medication delivery.
B) nebulizer solution.
Nebulizer solutions are typically delivered using a nebulizer device that converts liquid medication into a mist. This method of administration does not involve the use of a metered-dose inhaler or a spacer, making this option incorrect in the context of the question.
C) dry powder inhaler.
A dry powder inhaler (DPI) operates on a different principle than a metered-dose inhaler. DPIs require the patient to inhale forcefully to activate the medication release, and they do not utilize spacers. Therefore, this option does not apply to the use of a spacer.
D) metered-dose inhaler.
A spacer is specifically designed to be used with a metered-dose inhaler to facilitate better inhalation of medication. It allows for a more effective delivery of aerosolized drugs, especially for patients who struggle with the timing of inhalation and actuation.
Conclusion
The use of a spacer with a metered-dose inhaler significantly enhances medication delivery to the lungs, making it the correct choice among the options provided. Other choices, such as nasal sprays, nebulizer solutions, and dry powder inhalers, do not utilize spacers, highlighting the unique application of spacers in conjunction with MDIs.
Answer: D
A pharmacy that discovers the theft of a controlled substance must notify the Drug Enforcement Administration.
When a pharmacy discovers the theft of a controlled substance, it is required by federal regulations to notify the Drug Enforcement Administration (DEA) as part of compliance and reporting measures.
A) local law enforcement
While notifying local law enforcement may be a prudent step, it is not a federal requirement specifically outlined for pharmacies regarding the theft of controlled substances. Local law enforcement's involvement may vary depending on the jurisdiction and circumstance.
B) the State Board of Pharmacy
Notifying the State Board of Pharmacy is important for regulatory compliance; however, federal regulations specifically mandate notification to the DEA in cases of controlled substance theft, making this option insufficient on its own.
C) the Food and Drug Administration
The Food and Drug Administration (FDA) primarily oversees the safety and efficacy of medications rather than the regulation of controlled substances. Therefore, this option is not relevant in the context of reporting thefts of controlled substances.
D) the Drug Enforcement Administration
This is the correct answer because the Drug Enforcement Administration is the federal agency responsible for enforcing the controlled substances laws and regulations. Pharmacies must report any theft of controlled substances directly to the DEA to ensure proper follow-up and compliance with the law.
Conclusion
The requirement to notify the Drug Enforcement Administration underscores the importance of monitoring and controlling the distribution of controlled substances. All other options, while potentially relevant in different contexts, do not fulfill the specific federal requirement mandated for pharmacies in the event of a theft. Thus, D is the definitive correct answer.
Answer: A
Zafirlukast may be an appropriate therapeutic substitution for Singulair.
Zafirlukast serves as a leukotriene receptor antagonist, similar to Singulair, making it a suitable alternative for patients requiring similar therapeutic effects in managing asthma or allergic rhinitis.
A) Zafirlukast
Zafirlukast is a leukotriene receptor antagonist that works by blocking the action of leukotrienes, which are substances in the body that cause asthma and allergic symptoms. This mechanism aligns closely with that of Singulair, making Zafirlukast an appropriate therapeutic substitution for patients who might need an alternative due to cost, availability, or specific patient considerations.
B) Ziprasidone
Ziprasidone is an atypical antipsychotic medication primarily used to treat schizophrenia and bipolar disorder. It does not share the same mechanism of action or therapeutic indications as Singulair, thus making it an inappropriate choice for substitution in the context of asthma or allergic conditions.
C) Zolpidem
Zolpidem is a sedative-hypnotic used for the short-term treatment of insomnia. It does not address the underlying issues of asthma or allergic rhinitis and therefore cannot serve as a therapeutic substitution for Singulair, which targets respiratory conditions.
D) Zaleplon
Zaleplon is another sedative used to treat insomnia, similar to Zolpidem. Like Zolpidem, it does not interact with the pathways that Singulair affects, making it an unsuitable option for therapeutic substitution in the management of asthma or allergies.
Conclusion
Zafirlukast is the only option that directly aligns with the therapeutic goals of Singulair, making it the definitive choice for substitution. Other options like Ziprasidone, Zolpidem, and Zaleplon serve entirely different therapeutic purposes and do not address the same health issues, highlighting their inappropriateness in this context.
Answer: D
Pregnancy considerations would be found in the package insert.
The package insert for a medication typically includes crucial information about its safety and usage, particularly regarding pregnancy considerations. This section informs healthcare providers and patients about any known risks or precautions necessary when the medication is used during pregnancy.
A) Off-label indication
Off-label indications are not typically included in the package insert as they refer to uses of the medication that are not approved by regulatory agencies. The package insert focuses on the approved uses and indications, making this option incorrect.
B) Cost
The cost of a medication is not included in the package insert. Pricing information is variable and can differ by pharmacy and insurance coverage, thus this option does not pertain to the information found in the insert.
C) Therapeutic equivalences
Therapeutic equivalences are generally not detailed in the package insert. This information is usually found in separate references or databases that assess medications for their equivalency, making this option incorrect.
D) Pregnancy considerations
The package insert provides essential details regarding pregnancy considerations, including any potential risks associated with the medication during pregnancy. This information is vital for healthcare providers when prescribing medications to pregnant individuals.
Conclusion
The correct answer, pregnancy considerations, is a fundamental component of the package insert, as it ensures that healthcare professionals are aware of any risks when prescribing to pregnant patients. The other options fail to meet the criteria of information typically found in a package insert, highlighting the importance of understanding the specific content included in these documents.
Answer: A
The best next step for the technician is to request to return the medication for credit.
When a box of Basaglar KwikPen arrives frozen, it is crucial to ensure the integrity of the medication. Requesting to return the medication for credit is the appropriate action, as freezing can compromise the efficacy and safety of the insulin product.
A) request to return the medication for credit
This option is correct because medications that have been exposed to freezing temperatures may no longer be safe or effective for patient use. Returning the medication for credit ensures that it will not be dispensed and can be replaced with a properly stored product.
B) store the medication in the freezer
Storing the medication in the freezer is incorrect because freezing can damage the formulation of Basaglar, leading to potential loss of effectiveness. Insulin should be stored according to the manufacturer's recommendations, which typically do not include freezing.
C) discard the medication with P-listed waste
While it is important to dispose of medications that cannot be used, discarding the medication with P-listed waste is not the next step in this situation. Instead, returning the medication allows for proper handling and potential replacement, rather than immediate disposal.
D) send the medication to the FDA for inspection
Sending the medication to the FDA for inspection is not practical or necessary in this case. The FDA does not inspect individual shipments; instead, the pharmacy technician should return the medication to the wholesaler for credit, as the medication's safety could be compromised.
Conclusion
Requesting to return the medication for credit is the definitive right action in this scenario, as it prioritizes patient safety and ensures that compromised medications are not dispensed. The other options fail as they either involve improper storage or unnecessary disposal, neglecting the importance of ensuring medication integrity.
Answer: C
The NDC number identifies the drug, the specific dosage form, the strength, and the manufacturer.
The National Drug Code (NDC) number is a unique identifier that provides detailed information about a drug, including its specific dosage form, strength, and the manufacturer. This coding system is essential for identifying and tracking medications in the healthcare system.
A) NABP number
The NABP number is associated with the National Association of Boards of Pharmacy and serves as a credentialing identifier for pharmacies, but it does not provide specific information about the drug, its dosage form, or strength. Therefore, it is not the correct choice for identifying a drug.
B) Lot number
A lot number is used to identify a specific batch of a drug product for tracking and recall purposes, but it does not include information about the drug's strength, dosage form, or manufacturer. Thus, it does not fulfill the requirements of the question.
C) NDC number
The NDC number is the only option that encompasses all necessary information about a drug, including its name, dosage form, strength, and manufacturer. This makes it the definitive choice for identifying a drug in the context specified by the question.
D) Wholesaler order number
The wholesaler order number is used for inventory and ordering purposes within the pharmaceutical supply chain, but it does not provide any specific information about the drug itself, including its dosage form or manufacturer. Therefore, it is not relevant to the question.
Conclusion
The NDC number is the only option that comprehensively identifies a drug along with its dosage form, strength, and manufacturer, making it the correct response to the question. All other options fail to provide the complete information required, focusing instead on different aspects of drug distribution or identification.
Answer: B
2.5 mL will last for 12 days.
To determine how many days the 2.5 mL of eyedrops will last when used once daily in each eye, we first calculate the total number of drops available. With 15 drops per mL, 2.5 mL provides 37.5 drops. Since two drops are used each day (one for each eye), the drops will last for 12 days.
A) 6
This option is incorrect because if each day requires two drops, the total number of drops from 2.5 mL does not support only 6 days of usage. Six days would only account for 12 drops, which is less than the total available.
B) 12
This option is correct as it accurately reflects the calculation based on the total available drops. With 2.5 mL yielding 37.5 drops and using 2 drops per day, the drops last exactly 12 days.
C) 18
This option is incorrect because it suggests a longer duration than is possible with the given volume of drops. Using 18 days would require 36 drops, which exceeds the number of drops available from 2.5 mL.
D) 36
This option is incorrect as it implies a much greater number of days than the available drops can support. To last 36 days, 72 drops would be needed, which is well beyond the 37.5 drops obtainable from 2.5 mL.
Conclusion
The correct answer is 12 days, as it matches the calculation of the total drops available against the daily usage. All other options fail because they either understate or overstate the number of days based on the total drops derived from the prescription volume.
Answer: D
Thiamine is a vitamin.
Thiamine, also known as vitamin B1, plays a crucial role in energy metabolism and is essential for the proper functioning of the nervous system.
A) diuretic.
Diuretics are substances that promote the excretion of urine and are typically used to manage conditions such as high blood pressure or edema. Thiamine does not have diuretic properties and therefore is not classified as a diuretic.
B) bronchodilator.
Bronchodilators are medications that relax the muscles of the airways, making it easier to breathe for individuals with respiratory conditions such as asthma. Thiamine does not have bronchodilating effects and is not used in this capacity.
C) antibiotic.
Antibiotics are drugs that kill or inhibit the growth of bacteria. Thiamine does not exhibit antibacterial properties and is not classified as an antibiotic, making this option incorrect.
D) vitamin.
Thiamine is classified as a vitamin, specifically vitamin B1. It is crucial for the metabolism of carbohydrates and is vital for maintaining healthy nerve and muscle function.
Conclusion
Thiamine is definitively classified as a vitamin, specifically vitamin B1, which is essential for various metabolic processes in the body. The other options—diuretic, bronchodilator, and antibiotic—do not accurately represent the role or classification of thiamine, reinforcing that option D is the correct choice.